퓨시드산(Fusidic Acid) 시장 : 산업 규모, 점유율, 동향, 기회, 예측, 판매채널별(직접, 간접), 최종 용도별(농가진, 봉와직염, 절상 및 창상, 눈감염, 기타), 지역별, 경쟁별(2020-2030년)
Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region and Competition, 2020-2030F
퓨시드산 세계 시장은 2024년에 2,971만 달러로 평가되었고, 2030년에는 4,212만 달러에 달할 것으로 예상되며, 예측 기간 동안 2.02%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. 시장 성장은 특히 피부 및 연조직에 영향을 미치는 세균성 감염증의 치료에서 퓨시드산의 사용 확대로 인해 꾸준히 성장하고 있습니다.
| 시장 개요 |
| 예측 기간 |
2026-2030년 |
| 시장 규모 : 2024년 |
2,971만 달러 |
| 시장 규모 : 2030년 |
4,212만 달러 |
| CAGR : 2025-2030년 |
2.02% |
| 급성장 부문 |
직접 |
| 최대 시장 |
아시아태평양 |
퓨시드산은 주로 메티실린 내성균(MRSA)을 포함한 황색포도상구균에 의한 감염을 치료하는 데 사용되는 강력한 항생제로, 외용제와 경구제 모두 일반적으로 사용 가능하며 병원과 지역사회 모두에서 우려의 목소리가 커지고 있습니다. 항생제 내성이 전 세계적으로 심각한 문제로 대두되고 있는 가운데, 퓨시드산과 같은 효과적인 대체 약물에 대한 필요성이 증가하고 있습니다.
이 항생제는 의약품 및 피부과 제제에 널리 사용되며, 특히 전염성 농피증, 모낭염, 봉와직염과 같은 피부 질환의 치료에 중점을 두고 있습니다. 세계 인구의 고령화와 함께 이러한 감염성 질환의 발병률이 증가하고 있으며, 이는 다양한 지역에서 푸시딘산에 대한 수요를 촉진하고 있습니다. 또한, 항생제 내성에 대한 인식이 높아지면서 퓨시드산 기반 치료에 대한 관심이 높아지고 있습니다. 세계 시장 특징은 브랜드 의약품과 제네릭 의약품이 혼합되어 있다는 점이며, 제네릭 의약품은 저렴한 가격과 폭넓은 가용성으로 인해 점점 더 많은 지지를 받고 있습니다.
주요 시장 성장 촉진요인
세계 헬스케어 산업의 확장
주요 시장 이슈
안전성 우려와 부작용
주요 시장 동향
안구감염증 증가
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 COVID-19가 세계의 퓨시드산 시장에 미치는 영향
제5장 세계의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 판매채널별(직접, 간접)
- 용도별(전염성 농가진, 봉와직염, 절상, 눈감염증, 기타)
- 지역별
- 기업별(2024년)
- 시장 맵
제6장 북미의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 북미 : 국가별 분석
제7장 유럽의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 유럽 : 국가별 분석
제8장 아시아태평양의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 아시아태평양 : 국가별 분석
제9장 남미의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 남미 : 국가별 분석
제10장 중동 및 아프리카의 퓨시드산 시장 전망
- 시장 규모와 예측
- 시장 점유율과 예측
- 중동 및 아프리카 : 국가별 분석
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
제11장 시장 역학
제12장 시장 동향과 발전
제13장 세계의 퓨시드산 시장 : SWOT 분석
제14장 Porter의 Five Forces 분석
- 업계내 경쟁
- 신규 참여 가능성
- 공급업체의 힘
- 고객의 힘
- 대체품의 위협
제15장 경쟁 구도
- Ercros S.A
- Emote Life sciences LLP
- Kaniwa Bioscience Pvt. Ltd
- Concord Biotech Limited
- Fleming Laboratories Ltd
- Sterling Biotech Ltd
- Oliver Pharmaceuticals
- Apex Healthcare Ltd
- Horster Life Sciences Pvt. Ltd.
- Celaxis Bioscience Pvt Ltd
제16장 전략적 제안
제17장 리서치사에 대해 & 면책사항
LSH
Global Fusidic Acid Market was valued at USD 29.71 million in 2024 and is projected to reach USD 42.12 million by 2030, growing at a compound annual growth rate (CAGR) of 2.02% over the forecast period. Market growth is being steadily driven by the increasing application of fusidic acid in treating bacterial infections, particularly those affecting the skin and soft tissues.
| Market Overview |
|---|
| Forecast Period | 2026-2030 |
| Market Size 2024 | USD 29.71 Million |
| Market Size 2030 | USD 42.12 Million |
| CAGR 2025-2030 | 2.02% |
| Fastest Growing Segment | Direct |
| Largest Market | Asia-Pacific |
Fusidic acid is a potent antibiotic commonly available in both topical and oral formulations, primarily used to treat infections caused by Staphylococcus aureus, including methicillin-resistant strains (MRSA), which are a growing concern in both hospital and community settings. As antibiotic resistance becomes an escalating global issue, the need for effective alternatives such as fusidic acid is gaining momentum.
This antibiotic is widely used in pharmaceutical and dermatological formulations, with a particular focus on treating skin conditions like impetigo, folliculitis, and cellulitis. The rising incidence of these infections, coupled with an aging global population, is fueling demand for fusidic acid across various geographies. Additionally, heightened awareness surrounding antibiotic resistance has intensified interest in fusidic acid-based treatments. The global market is characterized by a mix of branded and generic products, with generic formulations increasingly gaining traction due to their affordability and broader availability.
Key Market Drivers
Expansion of the Global Healthcare Industry
The ongoing growth of the global healthcare sector is a significant catalyst for the fusidic acid market. Worldwide healthcare sales are projected to surpass USD 4 trillion annually, with pharmaceuticals and biotechnology representing the most substantial segments-generating close to USD 850 billion-followed by medical technology and diagnostics at over USD 400 billion.
Fusidic acid is recognized as a valuable therapeutic solution for a range of bacterial infections, including skin, eye, and soft tissue infections. As the demand for targeted and effective treatments rises, driven by the increasing incidence of bacterial infections and improvements in healthcare infrastructure and accessibility, the market for fusidic acid continues to expand.
Key Market Challenges
Safety Concerns and Adverse Effects
One of the primary concerns surrounding the use of fusidic acid is its potential hepatotoxicity. Prolonged use or high dosages can lead to liver complications such as hepatitis or jaundice-particularly in patients with existing liver conditions, thereby increasing the risk of adverse reactions. As a result, patients undergoing treatment with fusidic acid often require regular liver function monitoring to mitigate risks.
These safety considerations limit the duration for which fusidic acid can be prescribed, posing challenges in cases that demand long-term antibiotic therapy. In addition, while topical formulations are widely used for skin infections, they can cause local side effects such as irritation, redness, itching, or rashes-sometimes resulting in treatment discontinuation among sensitive individuals.
Although rare, allergic reactions-including severe responses such as anaphylaxis-can occur, especially in immunocompromised populations. These potential risks may hinder wider market adoption. To address this, manufacturers must implement clear labeling, patient education, and effective monitoring practices to ensure safe and informed usage.
Key Market Trends
Rising Incidence of Eye Infections
A notable trend propelling the global fusidic acid market is the increasing prevalence of bacterial eye infections. According to the World Health Organization (WHO), trachoma alone is responsible for approximately 1.9 million cases of blindness or visual impairment across 42 countries, representing 1.4% of global blindness. The economic burden associated with this condition is estimated between USD 2.9 billion and USD 5.3 billion annually.
Bacterial eye infections caused by pathogens such as Staphylococcus aureus and Streptococcus pneumoniae are on the rise due to several factors, including environmental pollution, rapid urbanization, and lifestyle-related changes. Fusidic acid, known for its efficacy in treating localized bacterial infections, has emerged as a key solution for conditions such as bacterial conjunctivitis, blepharitis, and keratitis.
This upward trend is further supported by increasing exposure to environmental irritants, allergens, and extended screen time, all of which contribute to eye dryness and a higher risk of infection. Additionally, the growing global use of contact lenses-particularly in urban populations-has led to a rise in bacterial eye infections linked to poor hygiene and prolonged wear. These factors are driving the demand for fusidic acid-based ophthalmic treatments, reinforcing its role in the evolving landscape of infectious disease management.
Key Market Players
- Ercros S.A
- Emote Life sciences LLP
- Kaniwa Bioscience Pvt. Ltd
- Concord Biotech Limited
- Fleming Laboratories Ltd
- Sterling Biotech Ltd
- Oliver Pharmaceuticals
- Apex Healthcare Ltd
- Horster Life Sciences Pvt. Ltd.
- Celaxis Bioscience Pvt Ltd
Report Scope
In this report, the Global Fusidic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Fusidic Acid Market, By Sales Channel:
Fusidic Acid Market, By End Use:
- Impetigo
- Cellulitis
- Cuts & Wounds
- Eye Infection
- Others
Fusidic Acid Market, By Region:
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Fusidic Acid Market.
Available Customizations:
Global Fusidic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Fusidic Acid Market
5. Global Fusidic Acid Market Outlook
- 5.1. Market Size & Forecast
- 5.2. Market Share & Forecast
- 5.2.1. By Sales Channel (Direct, Indirect)
- 5.2.2. By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2024)
- 5.3. Market Map
6. North America Fusidic Acid Market Outlook
- 6.1. Market Size & Forecast
- 6.2. Market Share & Forecast
- 6.2.1. By Sales Channel
- 6.2.2. By End Use
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Fusidic Acid Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Sales Channel
- 6.3.1.2.2. By End Use
- 6.3.2. Mexico Fusidic Acid Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Sales Channel
- 6.3.2.2.2. By End Use
- 6.3.3. Canada Fusidic Acid Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Sales Channel
- 6.3.3.2.2. By End Use
7. Europe Fusidic Acid Market Outlook
- 7.1. Market Size & Forecast
- 7.2. Market Share & Forecast
- 7.2.1. By Sales Channel
- 7.2.2. By End Use
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. France Fusidic Acid Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Sales Channel
- 7.3.1.2.2. By End Use
- 7.3.2. Germany Fusidic Acid Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Sales Channel
- 7.3.2.2.2. By End Use
- 7.3.3. United Kingdom Fusidic Acid Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Sales Channel
- 7.3.3.2.2. By End Use
- 7.3.4. Italy Fusidic Acid Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Sales Channel
- 7.3.4.2.2. By End Use
- 7.3.5. Spain Fusidic Acid Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Sales Channel
- 7.3.5.2.2. By End Use
8. Asia Pacific Fusidic Acid Market Outlook
- 8.1. Market Size & Forecast
- 8.2. Market Share & Forecast
- 8.2.1. By Sales Channel
- 8.2.2. By End Use
- 8.2.3. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Fusidic Acid Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Sales Channel
- 8.3.1.2.2. By End Use
- 8.3.2. India Fusidic Acid Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Sales Channel
- 8.3.2.2.2. By End Use
- 8.3.3. South Korea Fusidic Acid Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Sales Channel
- 8.3.3.2.2. By End Use
- 8.3.4. Japan Fusidic Acid Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Sales Channel
- 8.3.4.2.2. By End Use
- 8.3.5. Australia Fusidic Acid Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Sales Channel
- 8.3.5.2.2. By End Use
9. South America Fusidic Acid Market Outlook
- 9.1. Market Size & Forecast
- 9.2. Market Share & Forecast
- 9.2.1. By Sales Channel
- 9.2.2. By End Use
- 9.2.3. By Country
- 9.3. South America: Country Analysis
- 9.3.1. Brazil Fusidic Acid Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Sales Channel
- 9.3.1.2.2. By End Use
- 9.3.2. Argentina Fusidic Acid Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Sales Channel
- 9.3.2.2.2. By End Use
- 9.3.3. Colombia Fusidic Acid Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Sales Channel
- 9.3.3.2.2. By End Use
10. Middle East and Africa Fusidic Acid Market Outlook
- 10.1. Market Size & Forecast
- 10.2. Market Share & Forecast
- 10.2.1. By Sales Channel
- 10.2.2. By End Use
- 10.2.3. By Country
- 10.3. MEA: Country Analysis
- 10.3.1. South Africa Fusidic Acid Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Sales Channel
- 10.3.1.2.2. By End Use
- 10.3.2. Saudi Arabia Fusidic Acid Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Sales Channel
- 10.3.2.2.2. By End Use
- 10.3.3. UAE Fusidic Acid Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Sales Channel
- 10.3.3.2.2. By End Use
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Fusidic Acid Market: SWOT Analysis
14. Porters Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Ercros S.A
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
- 15.2. Emote Life sciences LLP
- 15.3. Kaniwa Bioscience Pvt. Ltd
- 15.4. Concord Biotech Limited
- 15.5. Fleming Laboratories Ltd
- 15.6. Sterling Biotech Ltd
- 15.7. Oliver Pharmaceuticals
- 15.8. Apex Healthcare Ltd
- 15.9. Horster Life Sciences Pvt. Ltd.
- 15.10. Celaxis Bioscience Pvt Ltd
16. Strategic Recommendations
17. About Us & Disclaimer
